Japan World Biopharmaceutical Technology Expo (bioLIVE Japan) leads the development of biopharmaceutical technology in Japan. Focusing on life sciences, biotechnology, and innovative drugs, it drives innovation and industrial development in the biopharmaceutical field.

The previous Japan World Biopharmaceutical Technology Exhibition bioLIVE Japan had a total exhibition area of 30,000 square meters, with 712 participating companies from China, South Korea, India, Thailand, Russia, the United States, Germany, and more, attracting 24,800 attendees. In recent years, regenerative medicine and medium-molecule medicines such as peptides and nucleic acid drugs have also attracted much attention, and these new themes will be included, with seminars introducing the latest technologies, products, and delegated services.

With the continuous advancement of cutting-edge biotechnology and the emergence and listing of new target drugs and cell therapies, the biopharmaceutical industry has entered a new stage of rapid development. The Japan World Biopharmaceutical Technology Exhibition bioLIVE Japan is even more the best trade platform for Chinese biopharmaceutical technology companies to enter Japan.